Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Pietsch

Showing results (141-150 of 388) with videos related to

Pageof 39
Sort By:
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Journal of Neuropathology and Experimental Neurology|January 11, 2017
Genomic Alterations of Adamantinomatous and Papillary CraniopharyngiomaTobias Goschzik, Marco Gessi, Verena Dreschmann, et al.
Acta Neuropathologica Communications|November 26, 2025
Recurrent genetic alterations in epigenetically defined pineoblastoma subtypesTobias Goschzik, Mathias Yuan, Elke Pfaff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular markers in low-grade gliomas: predictive or prognostic?Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTENWolfgang Hartmann, Boris Digon-Söntgerath, Arend Koch, et al.
Journal of Neuro-Oncology|May 6, 2016
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsKristian W Pajtler, Stephan Tippelt, Nele Siegler, et al.
Molecular and Cellular Biology|January 26, 2002
Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumorsBarbara Lustig, Boris Jerchow, Martin Sachs, et al.
The American Journal of Pathology|March 29, 2005
Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cellsWolfgang Hartmann, Arend Koch, Hendrik Brune, et al.
Frontiers in Neurology|July 5, 2018
Concurrent <i>IDH1</i> and <i>SMARCB1</i> Mutations in Pediatric Medulloblastoma: A Case ReportMoatasem El-Ayadi, Kristof Egervari, Doron Merkler, et al.
Neuro-Oncology Practice|August 7, 2019
Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004Tineke Boesten, Nicolas U Gerber, Daniela Kandels, et al.
Pageof 39

Showing results (141-150 of 388) with videos related to

Sort By:
Pageof 39
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Journal of Neuropathology and Experimental Neurology|January 11, 2017
Genomic Alterations of Adamantinomatous and Papillary CraniopharyngiomaTobias Goschzik, Marco Gessi, Verena Dreschmann, et al.
Acta Neuropathologica Communications|November 26, 2025
Recurrent genetic alterations in epigenetically defined pineoblastoma subtypesTobias Goschzik, Mathias Yuan, Elke Pfaff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular markers in low-grade gliomas: predictive or prognostic?Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTENWolfgang Hartmann, Boris Digon-Söntgerath, Arend Koch, et al.
Journal of Neuro-Oncology|May 6, 2016
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsKristian W Pajtler, Stephan Tippelt, Nele Siegler, et al.
Molecular and Cellular Biology|January 26, 2002
Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumorsBarbara Lustig, Boris Jerchow, Martin Sachs, et al.
The American Journal of Pathology|March 29, 2005
Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cellsWolfgang Hartmann, Arend Koch, Hendrik Brune, et al.
Frontiers in Neurology|July 5, 2018
Concurrent <i>IDH1</i> and <i>SMARCB1</i> Mutations in Pediatric Medulloblastoma: A Case ReportMoatasem El-Ayadi, Kristof Egervari, Doron Merkler, et al.
Neuro-Oncology Practice|August 7, 2019
Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004Tineke Boesten, Nicolas U Gerber, Daniela Kandels, et al.
Pageof 39